Katz Y, Armstrong D T
Endocrinology. 1976 Dec;99(6):1442-7. doi: 10.1210/endo-99-6-1442.
Serum estradiol-17beta levels, elevated prior to the luteinizing hormone (LH) surge, decline abruptly following the release of endogenous LH or the injection of exogenous LH. To investigate the mechanism of this decline, bovine LH (NIH-LH-B8) was administered to immature rats, in which follicular maturation and estrogen biosynthesis were induced by a non-ovulating dose of pregnant mare serum gonadotropin (PMS). Serum and ovarian estradiol-17beta concentrations fell detectably by 4h, and reached levels around 20% of the controls by 8h after iv injection of 10 mug LH. Concomitant decreases occurred in ovarian androgen concentrations, following an initial rise, and in the in vitro ovarian testosterone aromatizing enzyme activity. The LH-induced inhibition of the aromatase activity was found to be of a non-competitive type. It is proposed that two enzyme systems are inhibited as a result of the LH treatment: the C17,20-lyase and the C19 androgen aromatase, thereby leading to decreased concentrations of estrogens in the ovaries and blood.
在促黄体生成素(LH)峰出现之前升高的血清雌二醇-17β水平,在内源性LH释放或注射外源性LH后会急剧下降。为了研究这种下降的机制,将牛LH(NIH-LH-B8)给予未成熟大鼠,这些大鼠的卵泡成熟和雌激素生物合成是由非排卵剂量的孕马血清促性腺激素(PMS)诱导的。静脉注射10微克LH后4小时,血清和卵巢中的雌二醇-17β浓度可检测到下降,8小时后达到对照组水平的约20%。卵巢雄激素浓度在最初升高后随之下降,同时体外卵巢睾酮芳香化酶活性也下降。发现LH诱导的芳香化酶活性抑制为非竞争性类型。有人提出,LH处理导致两种酶系统受到抑制:17,20-裂解酶和C19雄激素芳香化酶,从而导致卵巢和血液中雌激素浓度降低。